{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:05Z","timestamp":1753890545409,"version":"3.41.2"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Heart failure through the spectrum of reduced (HFrEF), mid-range (or mildly reduced or HFmEF), and preserved ejection fraction (HFpEF), continues to plague patients' quality of life through recurrent admissions and high mortality rates. Despite tremendous innovation in medical therapy, patients continue to experience refractory congestive symptoms due to adverse left ventricular remodeling, significant functional mitral regurgitation (FMR), and right-sided failure symptoms due to significant functional tricuspid regurgitation (FTR). As most of these patients are surgically challenging for open cardiac surgery, the past decade has seen the development and evolution of different percutaneous structural interventions targeted at improving FMR and FTR. There is renewed interest in the sphere of left ventricular restorative devices to effect reverse remodeling and thereby improve effective stroke volume and patient outcomes. For patients suffering from HFpEF, there is still a paucity of disease-modifying effective medical therapies, and these patients continue to have recurrent heart failure exacerbations due to impaired left ventricular relaxation and high filling pressures. Structural therapies involving the implantation of inter-atrial shunt devices to decrease left atrial pressure and the development of implantable devices in the pulmonary artery for real-time hemodynamic monitoring would help redefine treatment and outcomes for patients with HFpEF. Lastly, there is pre-clinical data supportive of soft robotic cardiac sleeves that serve to improve cardiac function, can assist contraction as well as relaxation of the heart, and have the potential to be customized for each patient. In this review, we focus on the role of structural interventions in heart failure as it stands in current clinical practice, evaluate the evidence amassed so far, and review promising structural therapies that may transform the future of heart failure management.<\/jats:p>","DOI":"10.3389\/fcvm.2022.839483","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:22:08Z","timestamp":1650536528000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Restructuring the Heart From Failure to Success: Role of Structural Interventions in the Realm of Heart Failure"],"prefix":"10.3389","volume":"9","author":[{"given":"Devika","family":"Kir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrudula","family":"Munagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Prevention statistics, and S. Stroke statistics, heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.hfc.2017.02.001","article-title":"Epidemiology, pathophysiology, and prognosis of heart failure in older adults","volume":"13","author":"Dharmarajan","year":"2017","journal-title":"Heart Fail Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"701243","DOI":"10.3389\/fcvm.2021.701243","article-title":"Secondary tricuspid regurgitation: pathophysiology, incidence and prognosis","volume":"8","author":"Gercek","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1056\/NEJMcp1903331","article-title":"Secondary mitral regurgitation","volume":"383","author":"O'Gara","year":"2020","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/eurheartj\/ehab086","article-title":"The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC","volume":"42","author":"Coats","year":"2021","journal-title":"Eur Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamacardio.2017.2976","article-title":"Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis","volume":"2","author":"Sannino","year":"2017","journal-title":"J Am Med Assoc Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/eurjhf\/hfp051","article-title":"Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction","volume":"11","author":"Agricola","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ehjci\/jez073","article-title":"MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results","volume":"20","author":"Pibarot","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B14","doi-asserted-by":"publisher","first-page":"576058","DOI":"10.3389\/fcvm.2020.576058","article-title":"Indirect mitral annuloplasty using the carillon device","volume":"7","author":"Krishnaswamy","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.jacc.2006.07.043","article-title":"In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty","volume":"48","author":"Choure","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.109.849885","article-title":"Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study","volume":"120","author":"Schofer","year":"2009","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/eurjhf\/hfs076","article-title":"Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial","volume":"14","author":"Siminiak","year":"2012","journal-title":"Eur J Heart Fail."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e000411","DOI":"10.1136\/openhrt-2016-000411","article-title":"Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial","volume":"3","author":"Lipiecki","year":"2016","journal-title":"Open Heart"},{"key":"B19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jchf.2019.06.011","article-title":"The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation","volume":"7","author":"Witte","year":"2019","journal-title":"JACC Heart Fail."},{"journal-title":"The EMPOWER Trial - The Carillon","year":"2017","key":"B20"},{"key":"B21","doi-asserted-by":"publisher","first-page":"i26","DOI":"10.1093\/ejcts\/ezy410","article-title":"The role of transcatheter mitral valve therapy in heart failure","volume":"55","author":"Treede","year":"2019","journal-title":"Eur J Cardiothorac Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.21037\/acs.2018.10.10","article-title":"The cardioband transcatheter annular reduction system","volume":"7","author":"Miller","year":"2018","journal-title":"Ann Cardiothorac Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jcin.2016.07.005","article-title":"Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the cardioband percutaneous mitral repair system","volume":"9","author":"Nickenig","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"journal-title":"Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE) (ACTIVE)","year":"2017","key":"B24"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.jacc.2016.03.591","article-title":"Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system","volume":"67","author":"Nickenig","year":"2016","journal-title":"J Am Coll Cardiol."},{"journal-title":"MERIT Study - Mistral Percutaneous Mitral Valve Repair FIM Study (MERIT)","year":"2016","key":"B26"},{"key":"B27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.120.053061","article-title":"Relationship between residual mitral regurgitation and clinical and quality-of-life outcomes after transcatheter and medical treatments in heart failure: COAPT Trial","volume":"144","author":"Kar","year":"2021","journal-title":"Circulation."},{"journal-title":"CardiAQ-Edwards\u2122 Transcatheter Mitral Valve Replacement (TMVR) Study (RELIEF)","year":"2016","key":"B28"},{"key":"B29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.21037\/acs.2018.10.03","article-title":"Early experience with the Intrepid system for transcatheter mitral valve replacement","volume":"7","author":"Sorajja","year":"2018","journal-title":"Ann Cardiothorac Surg."},{"journal-title":"Transcatheter Mitral Valve Replacement With the Medtronic Intrepid\u2122 TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)","year":"2017","key":"B30"},{"key":"B31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jcin.2021.10.018","article-title":"Thirty-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: intrepid TMVR early feasibility study results","volume":"15","author":"Zahr","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"journal-title":"HighLife\u2122 Transcatheter Mitral Valve Replacement System Study","year":"2016","key":"B32"},{"journal-title":"Feasibility Study of the HighLife 28 mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk","year":"2019","key":"B33"},{"journal-title":"Early Feasibility Study of the Neovasc Tiara\u2122 Mitral Valve System (TIARA-I)","year":"2014","key":"B34"},{"journal-title":"Tiara\u2122 Transcatheter Mitral Valve Replacement Study (TIARA-II)","year":"2017","key":"B35"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jacc.2021.08.060","article-title":"2-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation","volume":"78","author":"Muller","year":"2021","journal-title":"J Am Coll Cardiol."},{"journal-title":"Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT)","year":"2018","key":"B37"},{"journal-title":"AltaValve Early Feasibility Study Protocol","year":"2019","key":"B38"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.jcin.2020.06.040","article-title":"Transcatheter mitral valve replacement with the transseptal EVOQUE system","volume":"13","author":"Webb","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"journal-title":"Edwards EVOQUE Eos MISCEND Study","year":"2016","key":"B40"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2018.12.065","article-title":"Percutaneous transcatheter mitral valve replacement: first-in-human experience with a new transseptal system","volume":"73","author":"Webb","year":"2019","journal-title":"J Am Coll Cardiol."},{"journal-title":"The ENCIRCLE Trial (ENCIRCLE)","year":"2019","key":"B42"},{"journal-title":"AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System (AHEAD)","year":"2017","key":"B43"},{"key":"B44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11886-021-01524-0","article-title":"Current status of catheter-based mitral valve replacement","volume":"23","author":"Rawish","year":"2021","journal-title":"Curr Cardiol Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jtcvs.2006.08.049","article-title":"Emerging opportunities for cardiac surgeons within structural heart disease","volume":"132","author":"Stuge","year":"2006","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","article-title":"Burden of tricuspid regurgitation in patients diagnosed in the community setting","volume":"12","author":"Topilsky","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","article-title":"Impact of tricuspid regurgitation on long-term survival","volume":"43","author":"Nath","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5812\/cardiovascmed.10686","article-title":"Impact of severe tricuspid regurgitation on long term survival","volume":"2","author":"Sadeghpour","year":"2013","journal-title":"Res Cardiovasc Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jcin.2019.10.023","article-title":"Combined tricuspid and mitral versus isolated mitral valve repair for severe MR and TR: an analysis from the trivalve and TRAMI registries","volume":"13","author":"Mehr","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00392-020-01798-4","article-title":"Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair","volume":"110","author":"Geyer","year":"2021","journal-title":"Clin Res Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.athoracsur.2009.01.043","article-title":"Model for end-stage liver disease predicts mortality for tricuspid valve surgery","volume":"87","author":"Ailawadi","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcin.2021.10.033","article-title":"Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair","volume":"15","author":"Stolz","year":"2022","journal-title":"JACC Cardiovasc Interv."},{"key":"B53","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/eurheartj\/ehab679","article-title":"TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery","volume":"43","author":"Dreyfus","year":"2021","journal-title":"Eur Heart J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","article-title":"Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation","volume":"77","author":"Lurz","year":"2021","journal-title":"J Am Coll Cardiol."},{"journal-title":"TRILUMINATE Pivotal Trial","year":"2019","key":"B55"},{"key":"B56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2020.11.047","article-title":"Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation","volume":"77","author":"Kodali","year":"2021","journal-title":"J Am Coll Cardiol."},{"journal-title":"Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)","year":"2019","key":"B57"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.4244\/EIJ-D-20-01107","article-title":"Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study","volume":"16","author":"Nickenig","year":"2021","journal-title":"EuroIntervention."},{"key":"B59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcin.2020.10.017","article-title":"Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes","volume":"14","author":"Davidson","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcin.2018.10.022","article-title":"Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry","volume":"12","author":"Taramasso","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jacc.2017.01.054","article-title":"Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results","volume":"69","author":"Hahn","year":"2017","journal-title":"J Am Coll Cardiol."},{"journal-title":"Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) (SCOUT-II)","year":"2017","key":"B62"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.jcin.2020.05.050","article-title":"First-in-human transcatheter tricuspid valve repair: 30-day follow-up experience with the mistral device","volume":"13","author":"Planer","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jcin.2019.04.038","article-title":"Long-term outcomes of the FORMA transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation: insights from the first-in-human experience","volume":"12","author":"Asmarats","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcvm.2018.00140","article-title":"Treatment of tricuspid regurgitation with the FORMA repair system","volume":"5","author":"Perlman","year":"2018","journal-title":"Front Cardiovasc Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"194601","DOI":"10.3390\/jcm10194601","article-title":"Caval Valve Implantation (CAVI): an emerging therapy for treating severe tricuspid regurgitation","volume":"10","author":"Abdul-Jawad Altisent","year":"2021","journal-title":"J Clin Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4244\/EIJ-D-19-00901","article-title":"Treatment of severe tricuspid regurgitation in patients with advanced heart failure with CAval vein implantation of the edwards sapien XT VALve (TRICAVAL): a randomised controlled trial","volume":"15","author":"Dreger","year":"2020","journal-title":"EuroIntervention."},{"journal-title":"TRICUS STUDY Euro - Safety and Efficacy of the TricValve\u00ae Device","year":"2019","key":"B68"},{"key":"B69","doi-asserted-by":"publisher","first-page":"619558","DOI":"10.3389\/fcvm.2021.619558","article-title":"Update on transcatheter tricuspid valve replacement therapies","volume":"8","author":"Goldberg","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jamacardio.2018.4320","article-title":"Outcomes from transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and left ventricular ejection fraction less than 30%: a substudy from the TOPAS-TAVI registry","volume":"4","author":"Maes","year":"2019","journal-title":"J Am Med Assoc Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2016.08.009","article-title":"Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial","volume":"182","author":"Spitzer","year":"2016","journal-title":"Am Heart J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11897-020-00464-0","article-title":"Continuous-flow left ventricular assist devices and the aortic valve: interactions, issues, and surgical therapy","volume":"17","author":"Goodwin","year":"2020","journal-title":"Curr Heart Fail Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ccd.26280","article-title":"Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency","volume":"87","author":"Retzer","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"B74","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.healun.2019.06.024","article-title":"A new frontier for TAVR: aortic insufficiency in CF-LVAD patients","volume":"38","author":"Fried","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"B75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): a phase 2, randomized, sham-controlled trial","volume":"137","author":"Feldman","year":"2018","journal-title":"Circulation."},{"key":"B76","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1001\/jamacardio.2018.2936","article-title":"One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial","volume":"3","author":"Shah","year":"2018","journal-title":"J Am Med Assoc Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.jcin.2018.07.001","article-title":"Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-wave system","volume":"11","author":"Rodes-Cabau","year":"2018","journal-title":"JACC Cardiovasc Interv."},{"journal-title":"Reducing Lung CongestIon Symptoms in Advanced Heart Failure (RELIEVE-HF)","year":"2018","key":"B79"},{"key":"B80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4244\/EIJ-D-19-00342","article-title":"The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction","volume":"15","author":"Paitazoglou","year":"2019","journal-title":"EuroIntervention."},{"journal-title":"Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure, TCTMD","year":"2021","author":"Kriegel","key":"B81"},{"key":"B82","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B83","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/ejhf.1870","article-title":"Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail."},{"journal-title":"PROACTIVE-HF IDE Trial Heart Failure NYHA Class III (PROACTIVE-HF)","year":"2019","key":"B85"},{"key":"B86","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10741-018-9711-2","article-title":"Left ventricular restoration devices post myocardial infarction","volume":"23","author":"Hendriks","year":"2018","journal-title":"Heart Fail Rev."},{"journal-title":"Early Feasibility Evaluation of the AccuCinch\u00ae Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (CorCinch-HFrEF)","year":"2018","key":"B87"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/ejhf.1669","article-title":"Less invasive ventricular reconstruction for ischaemic heart failure","volume":"21","author":"Klein","year":"2019","journal-title":"Eur J Heart Fail."},{"journal-title":"BioVentrix Revivent TC\u2122 System Clinical Study (ALIVE Trial)","year":"2015","key":"B89"},{"key":"B90","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrcardio.2017.14","article-title":"Device therapy: a robotic heart sleeve to keep the beat","volume":"14","author":"Fernandez-Ruiz","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12265-018-9854-5","article-title":"Evaluation of the corinnova heart assist device in an acute heart failure model","volume":"12","author":"Hord","year":"2019","journal-title":"J Cardiovasc Transl Res."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.839483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:22:13Z","timestamp":1650536533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.839483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":91,"alternative-id":["10.3389\/fcvm.2022.839483"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.839483","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"article-number":"839483"}}